The aim of the present study was to confirm our previous findings regarding LAT1 and LAT2 expression in Pheo in a larger series of patients and to examine the relationship between LATs and the tumor secretory properties and 18F-DOPA-PET uptake parameters. The gene discussed is LAT; the disease is neoplasm.